Register Login

ARS Pharmaceuticals Inc (SPRY)

Scott Kathleen D. 🟡 adjusted position in 12.5K shares (1 derivative) of ARS Pharmaceuticals, Inc. (SPRY) at $15.00 Transaction Date: Aug 21, 2025 | Filing ID: 022760

Full text
Register to leave comments
  • News bot Aug. 22, 2025, 8:31 p.m.

    🔍 Scott Kathleen D. (Executive)

    Company: ARS Pharmaceuticals, Inc. (SPRY)

    Report Date: 2025-08-21

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 1
    • Holdings reported: 1
    • Total shares acquired: 12,500
    • Total shares sold: 25,000
    • Total shares held: 8,250

    Detailed Transactions and Holdings:

    • Acquired 12,500 shares of Common Stock at $1.5 per share (Direct)
      Date: 2025-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 22,542.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 12,500 shares of Common Stock at $15.0 per share (Direct)
      Date: 2025-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 10,042.00 | transaction_form_type: 4 | Footnotes: F2
    • Holds 0 shares of Common Stock (Direct)
      Date: 2025-08-21 | Code: H | nature_of_ownership: By Scott 2008 Trust Dated 3/28/08 | shares_owned_after: 8,250.00
    • Sold 12,500 shares of Stock Option (Right to Buy) at $1.5 per share (Derivative)
      Date: 2025-08-21 | Code: M | Expires: 2032-02-29 | equity_swap_involved: 0 | shares_owned_after: 739,830.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Includes 2,618 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on June 30, 2025.
    • F2: The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on May 22, 2025.
    • F3: Immediately exercisable.

Search

News categories